Teresa Di Desidero
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 15, 2020
Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients.
Journal: Clinical and experimental medicine
Published: May 12, 2020
Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
Journal: Pharmacological research
Published: January 25, 2020
Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.
Journal: Journal of endocrinological investigation
Published: July 14, 2019
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells.
Journal: Investigational new drugs
Published: April 24, 2019
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.
Journal: Scientific reports
Published: February 20, 2019
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics.
Journal: Biochemical pharmacology
Published: February 07, 2019
Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells.
Journal: Frontiers in oncology
Published: February 07, 2019
Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors.
Journal: Biochemical pharmacology
Published: February 22, 2018
Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation.
Journal: Future science OA
Published: February 13, 2018
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients.
Journal: Investigational new drugs
Published: January 11, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
Journal: Oncology reports
Published: November 01, 2017
Last Updated: 09/26/2026